Arrowstreet Capital, Limited Partnership Mannkind Corp Transaction History
Arrowstreet Capital, Limited Partnership
- $120 Billion
- Q1 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Mannkind Corp stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 2,716,429 shares of MNKD stock, worth $11.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,716,429
Previous 4,887,609
44.42%
Holding current value
$11.2 Million
Previous $31.4 Million
56.52%
% of portfolio
0.01%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding MNKD
# of Institutions
274Shares Held
172MCall Options Held
1.37MPut Options Held
241K-
Black Rock Inc. New York, NY22.6MShares$92.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$71.4 Million0.0% of portfolio
-
State Street Corp Boston, MA9.47MShares$39 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$36.1 Million0.71% of portfolio
-
Nitorum Capital, L.P. New York, NY7.79MShares$32.1 Million7.16% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.06B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...